PARATEK PHARMACEUTICALS INC - COM (PRTK)

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
22,760,195
Share change
-514,555
Total reported value
$42,556,232
Put/Call ratio
89%
Price per share
$1.87
Number of holders
76
Value change
-$1,370,362
Number of buys
32
Number of sells
34

Institutional Holders of PARATEK PHARMACEUTICALS INC - COM (PRTK) as of Q4 2022

As of 31 Dec 2022, PARATEK PHARMACEUTICALS INC - COM (PRTK) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,760,195 shares. The largest 10 holders included AIGH Capital Management LLC, VANGUARD GROUP INC, Omega Fund Management, LLC, GENERAL AMERICAN INVESTORS CO INC, Rock Springs Capital Management LP, Bruce & Co., Inc., BlackRock Inc., Abingworth LLP, Worth Venture Partners, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 76 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.